Order custom Harvard Business Case Study Analysis & Solution. Starting just $19
Eli Lilly: Developing Cymbalta Marketing Strategy Analysis & Solution
Marketing & Sales Case Study Analysis and Solution
At Fern Fort University, we use Harvard Business Review (HBR) marketing principles and framework to analyze Eli Lilly: Developing Cymbalta case study. Eli Lilly: Developing Cymbalta is a Harvard Business Review case study written by Elie Ofek, Ron Lauferfor the students of Sales & Marketing. The case study also include other relevant topics and learning material on – Marketing, Pricing, Product development
Strategic Marketing Analysis of Eli Lilly: Developing Cymbalta case study written by Elie Ofek, Ron Laufer will comprise following sections –
- Eli Lilly: Developing Cymbalta Case Description
- Marketing Definition
- Market Potential Analysis of Eli Lilly: Developing Cymbalta
- Market Share Potential Analysis
- Segmentation and Segment Attractiveness Analysis
- Competition and Competitiveness Analysis of Eli Lilly: Developing Cymbalta
- Customer Value Analysis of Eli Lilly: Developing Cymbalta case study
Eli Lilly: Developing Cymbalta Marketing Case Description
Sales & Marketing Case Study | Authors :: Elie Ofek, Ron Laufer
Anticipating the expiration of its Prozac patent, Eli Lilly has to make tough decisions regarding the development of its next-generation antidepressant drug. In particular, the company needs to decide whether to first establish that once-a-day dosing for Cymbalta (Duloxetine) is effective in treating major depressive disorder and only after launch get FDA approval for treating painful physical symptoms, or to first establish efficacy in treating pain and later get FDA approval for once-a-day dosing. The decision needs to take into account how Cymbalta can be differentiated in the marketplace vis-a-vis other antidepressants and the marketing challenges to getting adoption that the new drug will face. Lilly's new antidepressant team making this decision has several market research inputs on physicians and patients at its disposal.
Marketing, Pricing, Product development
According to American Marketing Association – Marketing is a set of activities that a firm undertakes for creating, communicating, delivering, & exchanging offerings that have value for customers, clients, partners, and society at large.
Kotler explains - Marketing is a process by which organizations can create value for its potential and current customers and build strong customer relationships in order to capture value in return.
Market Potential Analysis of Eli Lilly: Developing Cymbalta
Market potential analysis comprises evaluating the overall market size of the related product that the firm is planning to launch. This will involve defining – Why the target market segment needs the product and how it will provide a solution to full its consumers’ needs. Market potential of Eli Lilly: Developing Cymbalta products various on factors such as –
- Maturity of the market. In mature markets the profitability is often stable but the market potential is less as most of the players have already taken market share based on the segment they are serving. New players have to go for market share strategies in marketing.
- Technological competence of the existing players and culture of innovation and development in the industry.
- Untapped market sizes and barriers to both enter the market and serving the customers. Often companies can easily see the unfulfilled needs in the markets but they are difficult to serve as there are costly barriers.
- Define the core need that your product is serving and list out all the direct and indirect competitors in the market place. This will help not only in positioning of the product but also in defining or creating a segment better.
- Uncovering the current and untapped market sizes and barriers to serving the larger market. Analyze the areas that you need to sort out while launching the products to wider market and what are the challenges the firm will face in market place.
- Estimate the current stage in product life cycle and its implications for marketing decisions for the product.
Market Share Potential Analysis
- Understanding the buyer behavior model for Eli Lilly: Developing Cymbaltaindustry.
- Identifying the market share drivers relevant to Eli Lilly: Developing Cymbalta market.
- Segment Attractiveness Analysis – Our analysis will work out which are the most attractive segments and which are the one the firm should go ahead and target. We point out in great detail which segments will be most lucrative for the company to enter.
- Understanding the different needs and relative value of your offering by segment.
- Developing segment priorities and positioning the product based on the product need fit developed by the firm.
Competition & Competitive Position Analysis
- Uncovering customer-based competitive positions for key rivals and firm’s offering. This will not only help in assessing the strengths and weaknesses of the competitors but also help in defining and positioning of the product.
- Developing a positioning and launching strategy. It will require not only distribution channel analysis but also promotion mix for the product.
- Strategic Marketing Planning — the process of developing and maintaining a strategic fit between the organization’s objectives and capabilities and the ever evolving marketing opportunities for its products.
Eli Lilly: Developing Cymbalta - Customer Value Analysis
Capturing customer value is essential to marketing efforts as it results in higher return in the form of both current & future sales, greater market share, and higher profits. By creating superior customer value, the organization can create highly satisfied customers who stay loyal and buy more. This, in turn, means greater long-run returns for the firm.
- The crucial role of customer perceived value in acquiring and retaining profitable customers. Product differentiation is often based on building on a value niche that a firm believes that is very important to the customer. This niche contributes to perceived value. If the perceived value is high then customer stay loyal to the product if not then she can switch to the competitor’s product.
- Graphically displaying value differences for deeper understanding and better internal communication. This helps is building a narrative that a customer can identify with. The better the insight more are the chances of connecting with the potential customers.
- Identifying and selecting actionable value creation options. This can help in increasing the customer lifetime value. Customer lifetime value is the value of the entire stream of purchases that the customer would make over a lifetime of patronage.
NOTE: Every marketing case study solution varies based on the details and data provided in the case. We write unique marketing strategy case solution for each HBR case study with no plagiarism. The specific case dictate the exact format for the case study analysis.
You can order Eli Lilly: Developing Cymbalta Marketing Strategy Case Study Solution with us at Fern Fort University .
Next 5 Marketing Case Study Solution
- Metabical: Pricing, Packaging, and Demand Forecasting for a New Weight-Loss Drug Marketing Strategy Solution
- Healthymagination at GE Healthcare Systems Marketing Strategy Solution
- Johnson & Johnson: The Tylenol Tragedy Marketing Strategy Solution
- Product Team Cialis: Getting Ready to Market Marketing Strategy Solution
- Kramer Pharmaceuticals, Inc., Spanish Version Marketing Strategy Solution
Previous 5 Marketing Case Study Solution
- Cabot Pharmaceuticals, Inc. Marketing Strategy Solution
- Metabical: Positioning and Communications Strategy for a New Weight Loss Drug (Brief Case) Marketing Strategy Solution
- PROPECIA: Helping Make Hair Loss History Marketing Strategy Solution
- What's the Deal with LivingSocial? Marketing Strategy Solution
- Managing the Copy-Testing Process Marketing Strategy Solution
HBR Case Studies Solutions
- Metabical: Pricing, Packaging, and Demand Forecasting for a New Weight-Loss Drug Porter, SWOT,& PESTEL Analysis
- Healthymagination at GE Healthcare Systems Porter, SWOT,& PESTEL Analysis
- Johnson & Johnson: The Tylenol Tragedy Porter, SWOT,& PESTEL Analysis
- Product Team Cialis: Getting Ready to Market Porter, SWOT,& PESTEL Analysis
- Kramer Pharmaceuticals, Inc., Spanish Version Porter, SWOT,& PESTEL Analysis